パーキンソン病治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Parkinson’s Disease Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04990
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、104ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※当調査レポートでは、パーキンソン病治療の世界市場について調査・分析し、パーキンソン病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口、経皮、皮下、腸内注入）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界のパーキンソン病治療市場動向
・主要企業別マーケットシェア
・パーキンソン病治療の種類別市場規模2014-2019
（経口、経皮、皮下、腸内注入）
・パーキンソン病治療の用途別市場規模2014-2019
（病院薬局、小売薬局、オンライン薬局）
・パーキンソン病治療の北米市場：主要企業・種類別/用途別市場規模
・パーキンソン病治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・パーキンソン病治療の中国市場：主要企業・種類別/用途別市場規模
・パーキンソン病治療の日本国内市場：主要企業・種類別/用途別市場規模
・パーキンソン病治療の東南アジア市場：主要企業・種類別/用途別市場規模
・パーキンソン病治療のインド市場：主要企業・種類別/用途別市場規模
・パーキンソン病治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Teva、Roche、Prothena、Acorda Therapeutics、Voyager Therapeutics、Impax Pharmaceuticals、UCB、AbbVie、MSD、Orion Pharmaceuticals、Intec Pharma、NeuroDerm、Adamas Therapeutics、Acadia、Sunovion、GSK）
・パーキンソン病治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors such as aging, environmental factors/exposures, and genetic predispositions.In 2018, the global Parkinson’s Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Parkinson’s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson’s Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Teva
Roche
Prothena
Acorda Therapeutics
Voyager Therapeutics
Impax Pharmaceuticals
UCB
AbbVie
MSD
Orion Pharmaceuticals
Intec Pharma
NeuroDerm
Adamas Therapeutics
Acadia
Sunovion
GSK

Market segment by Type, the product can be split into
Oral
Transdermal
Subcutaneous
Intestinal Infusion

Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Parkinson’s Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Parkinson’s Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson’s Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Transdermal
1.4.4 Subcutaneous
1.4.5 Intestinal Infusion
1.5 Market by Application
1.5.1 Global Parkinson’s Disease Treatment Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Parkinson’s Disease Treatment Market Size
2.2 Parkinson’s Disease Treatment Growth Trends by Regions
2.2.1 Parkinson’s Disease Treatment Market Size by Regions (2019-2025)
2.2.2 Parkinson’s Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Parkinson’s Disease Treatment Market Size by by Players
3.1.1 Global Parkinson’s Disease Treatment Revenue by by Players (2014-2019)
3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Parkinson’s Disease Treatment Key Players Head office and Area Served
3.3 Key Players Parkinson’s Disease Treatment Product/Solution/Service
3.4 Date of Enter into Parkinson’s Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Parkinson’s Disease Treatment Market Size by Type (2014-2019)
4.2 Global Parkinson’s Disease Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Parkinson’s Disease Treatment Market Size (2014-2019)
5.2 Parkinson’s Disease Treatment Key Players in North America
5.3 North America Parkinson’s Disease Treatment Market Size by Type
5.4 North America Parkinson’s Disease Treatment Market Size by Application

6 Europe
6.1 Europe Parkinson’s Disease Treatment Market Size (2014-2019)
6.2 Parkinson’s Disease Treatment Key Players in Europe
6.3 Europe Parkinson’s Disease Treatment Market Size by Type
6.4 Europe Parkinson’s Disease Treatment Market Size by Application

7 China
7.1 China Parkinson’s Disease Treatment Market Size (2014-2019)
7.2 Parkinson’s Disease Treatment Key Players in China
7.3 China Parkinson’s Disease Treatment Market Size by Type
7.4 China Parkinson’s Disease Treatment Market Size by Application

8 Japan
8.1 Japan Parkinson’s Disease Treatment Market Size (2014-2019)
8.2 Parkinson’s Disease Treatment Key Players in Japan
8.3 Japan Parkinson’s Disease Treatment Market Size by Type
8.4 Japan Parkinson’s Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Parkinson’s Disease Treatment Market Size (2014-2019)
9.2 Parkinson’s Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Parkinson’s Disease Treatment Market Size by Type
9.4 Southeast Asia Parkinson’s Disease Treatment Market Size by Application

10 India
10.1 India Parkinson’s Disease Treatment Market Size (2014-2019)
10.2 Parkinson’s Disease Treatment Key Players in India
10.3 India Parkinson’s Disease Treatment Market Size by Type
10.4 India Parkinson’s Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Parkinson’s Disease Treatment Market Size (2014-2019)
11.2 Parkinson’s Disease Treatment Key Players in Central & South America
11.3 Central & South America Parkinson’s Disease Treatment Market Size by Type
11.4 Central & South America Parkinson’s Disease Treatment Market Size by Application

12 International Players Profiles
12.1 Teva
12.1.1 Teva Company Details
12.1.2 Company Description and Business Overview
12.1.3 Parkinson’s Disease Treatment Introduction
12.1.4 Teva Revenue in Parkinson’s Disease Treatment Business (2014-2019))
12.1.5 Teva Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Parkinson’s Disease Treatment Introduction
12.2.4 Roche Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Prothena
12.3.1 Prothena Company Details
12.3.2 Company Description and Business Overview
12.3.3 Parkinson’s Disease Treatment Introduction
12.3.4 Prothena Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.3.5 Prothena Recent Development
12.4 Acorda Therapeutics
12.4.1 Acorda Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Parkinson’s Disease Treatment Introduction
12.4.4 Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.4.5 Acorda Therapeutics Recent Development
12.5 Voyager Therapeutics
12.5.1 Voyager Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Parkinson’s Disease Treatment Introduction
12.5.4 Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.5.5 Voyager Therapeutics Recent Development
12.6 Impax Pharmaceuticals
12.6.1 Impax Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Parkinson’s Disease Treatment Introduction
12.6.4 Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.6.5 Impax Pharmaceuticals Recent Development
12.7 UCB
12.7.1 UCB Company Details
12.7.2 Company Description and Business Overview
12.7.3 Parkinson’s Disease Treatment Introduction
12.7.4 UCB Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.7.5 UCB Recent Development
12.8 AbbVie
12.8.1 AbbVie Company Details
12.8.2 Company Description and Business Overview
12.8.3 Parkinson’s Disease Treatment Introduction
12.8.4 AbbVie Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.8.5 AbbVie Recent Development
12.9 MSD
12.9.1 MSD Company Details
12.9.2 Company Description and Business Overview
12.9.3 Parkinson’s Disease Treatment Introduction
12.9.4 MSD Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.9.5 MSD Recent Development
12.10 Orion Pharmaceuticals
12.10.1 Orion Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Parkinson’s Disease Treatment Introduction
12.10.4 Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2014-2019)
12.10.5 Orion Pharmaceuticals Recent Development
12.11 Intec Pharma
12.12 NeuroDerm
12.13 Adamas Therapeutics
12.14 Acadia
12.15 Sunovion
12.16 GSK

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Parkinson’s Disease Treatment Key Market Segments
Table Key Players Parkinson’s Disease Treatment Covered
Table Global Parkinson’s Disease Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Oral Figures
Table Key Players of Oral
Figuer Transdermal Figures
Table Key Players of Transdermal
Figuer Subcutaneous Figures
Table Key Players of Subcutaneous
Figuer Intestinal Infusion Figures
Table Key Players of Intestinal Infusion
Table Global Parkinson’s Disease Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Parkinson’s Disease Treatment Market Share by Application in 2018 & 2025
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacy Case Studies
Figure Online Pharmacy Case Studies
Figure Parkinson’s Disease Treatment Report Years Considered
Figure Global Parkinson’s Disease Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Parkinson’s Disease Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Parkinson’s Disease Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Parkinson’s Disease Treatment Market Share by Regions 2014-2019
Figure Global Parkinson’s Disease Treatment Market Share by Regions 2014-2019
Figure Global Parkinson’s Disease Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Parkinson’s Disease Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Parkinson’s Disease Treatment Market Share by by Players (2014-2019)
Figure Global Parkinson’s Disease Treatment Market Share by by Players in 2018
Table Global Parkinson’s Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Parkinson’s Disease Treatment Product/Solution/Service
Table Date of Enter into Parkinson’s Disease Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Parkinson’s Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Parkinson’s Disease Treatment Market Size Share by Type (2014-2019)
Figure Global Parkinson’s Disease Treatment Market Size Market Share by Type (2014-2019)
Table Global Parkinson’s Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Parkinson’s Disease Treatment Market Size Share by Application (2014-2019)
Figure Global Parkinson’s Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Application in 2018
Figure North America Parkinson’s Disease Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Parkinson’s Disease Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Parkinson’s Disease Treatment Market Share (2018-2019)
Table North America Parkinson’s Disease Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Parkinson’s Disease Treatment Market Share by Type 2014-2019
Table North America Parkinson’s Disease Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Parkinson’s Disease Treatment Market Share by Application 2014-2019
Figure Europe Parkinson’s Disease Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Parkinson’s Disease Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Parkinson’s Disease Treatment Market Share (2018-2019)
Table Europe Parkinson’s Disease Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Parkinson’s Disease Treatment Market Share by Type 2014-2019
Table Europe Parkinson’s Disease Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Parkinson’s Disease Treatment Market Share by Application 2014-2019
Figure China Parkinson’s Disease Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Parkinson’s Disease Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Parkinson’s Disease Treatment Market Share (2018-2019)
Table China Parkinson’s Disease Treatment Market Size by Type 2014-2019 (Million US$)
Table China Parkinson’s Disease Treatment Market Share by Type 2014-2019
Table China Parkinson’s Disease Treatment Market Size by Application 2014-2019 (Million US$)
Table China Parkinson’s Disease Treatment Market Share by Application 2014-2019
Figure Japan Parkinson’s Disease Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Parkinson’s Disease Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Parkinson’s Disease Treatment Market Share (2018-2019)
Table Japan Parkinson’s Disease Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Parkinson’s Disease Treatment Market Share by Type 2014-2019
Table Japan Parkinson’s Disease Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Parkinson’s Disease Treatment Market Share by Application 2014-2019
Figure Southeast Asia Parkinson’s Disease Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Parkinson’s Disease Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Parkinson’s Disease Treatment Market Share (2018-2019)
Table Southeast Asia Parkinson’s Disease Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Parkinson’s Disease Treatment Market Share by Type 2014-2019
Table Southeast Asia Parkinson’s Disease Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Parkinson’s Disease Treatment Market Share by Application 2014-2019
Figure India Parkinson’s Disease Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Parkinson’s Disease Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Parkinson’s Disease Treatment Market Share (2018-2019)
Table India Parkinson’s Disease Treatment Market Size by Type 2014-2019 (Million US$)
Table India Parkinson’s Disease Treatment Market Share by Type 2014-2019
Table India Parkinson’s Disease Treatment Market Size by Application 2014-2019 (Million US$)
Table India Parkinson’s Disease Treatment Market Share by Application 2014-2019
Figure Central & South America Parkinson’s Disease Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Parkinson’s Disease Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Parkinson’s Disease Treatment Market Share (2018-2019)
Table Central & South America Parkinson’s Disease Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Parkinson’s Disease Treatment Market Share by Type 2014-2019
Table Central & South America Parkinson’s Disease Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Parkinson’s Disease Treatment Market Share by Application 2014-2019
Table Teva Company Details
Table Teva Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure Teva Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table Teva Recent Development
Table Roche Company Details
Table Roche Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table Roche Recent Development
Table Prothena Company Details
Table Prothena Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure Prothena Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table Prothena Recent Development
Table Acorda Therapeutics Company Details
Table Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure Acorda Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table Acorda Therapeutics Recent Development
Table Voyager Therapeutics Company Details
Table Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure Voyager Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table Voyager Therapeutics Recent Development
Table Impax Pharmaceuticals Company Details
Table Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure Impax Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table Impax Pharmaceuticals Recent Development
Table UCB Company Details
Table UCB Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure UCB Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table UCB Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure AbbVie Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table AbbVie Recent Development
Table MSD Company Details
Table MSD Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure MSD Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table MSD Recent Development
Table Orion Pharmaceuticals Company Details
Table Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business 2014-2019 (Million US$)
Figure Orion Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2014-2019)
Table Orion Pharmaceuticals Recent Development
Table Intec Pharma Company Details
Table NeuroDerm Company Details
Table Adamas Therapeutics Company Details
Table Acadia Company Details
Table Sunovion Company Details
Table GSK Company Details
Table Global Parkinson’s Disease Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Parkinson’s Disease Treatment Market Size Share by Regions (2019-2025)
Figure Global Parkinson’s Disease Treatment Market Size Share by Regions in 2025
Figure North America Parkinson’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Parkinson’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Parkinson’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Parkinson’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Parkinson’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Parkinson’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Parkinson’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Parkinson’s Disease Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Parkinson’s Disease Treatment Market Size by Product (2019-2025)
Figure Global Parkinson’s Disease Treatment Market Size by Product in 2025
Table Global Parkinson’s Disease Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Parkinson’s Disease Treatment Market Size by Application (2019-2025)
Figure Global Parkinson’s Disease Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

パーキンソン病治療の世界市場：市場規模・現状・予測

Global Parkinson's Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04991 2019年9月2日 94Pages
※当調査レポートでは、パーキンソン病治療の世界市場について調査・分析し、パーキンソン病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（レボドパ/カルビドパ、ドーパミン受容体作動薬、MAO阻害剤、...

ウルフパーキンソンホワイト症候群の治療の世界市場：市場規模・現状・予測

Global Wolff Parkinson White Syndrome Treatment Market Size, Status and Forecast 2019-2025
QYR9ST05080 2019年9月2日 99Pages
※当調査レポートでは、ウルフパーキンソンホワイト症候群の治療の世界市場について調査・分析し、ウルフパーキンソンホワイト症候群の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬、電気除細動、手術...

ウルフパーキンソンホワイト症候群の治療の世界市場：市場規模・現状・予測

クラッベ病治療の世界市場：市場規模・現状・予測

Global Krabbe Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04918 2019年9月2日 94Pages
※当調査レポートでは、クラッベ病治療の世界市場について調査・分析し、クラッベ病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗けいれん薬、筋弛緩薬、HSCT、その他）、用途別（病院、ASC）、...

ニューカッスル病治療の世界市場：市場規模・現状・予測

Global Newcastle Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9ST03955 2019年9月2日 92Pages
※当調査レポートでは、ニューカッスル病治療の世界市場について調査・分析し、ニューカッスル病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（弱毒生ワクチン、不活化ワクチン、複合ワクチン）、用途別（...

感染症治療の世界市場：市場規模・現状・予測

Global Infectious Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04492 2019年9月2日 94Pages
※当調査レポートでは、感染症治療の世界市場について調査・分析し、感染症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗菌薬、抗真菌薬、抗ウイルス薬）、用途別（病院及び診療所、小売薬局）、地域別...

痛風病治療の世界市場：市場規模・現状・予測

Global Gout Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04464 2019年9月2日 94Pages
※当調査レポートでは、痛風病治療の世界市場について調査・分析し、痛風病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（急性痛風、慢性痛風）、用途別（病院、診療所、在宅設定、その他）、地域別（北米...

パジェット病治療の世界市場：市場規模・現状・予測

Global Paget's Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9ST05767 2019年9月2日 93Pages
※当調査レポートでは、パジェット病治療の世界市場について調査・分析し、パジェット病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ビスホスホネート、カルシトニン類似体（サーモンカルシトニン）、鎮...

ウィルソン病の治療の世界市場：市場規模・現状・予測

Global Wilson`s Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04274 2019年9月2日 94Pages
※当調査レポートでは、ウィルソン病の治療の世界市場について調査・分析し、ウィルソン病の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬、その他）、用途別（政府、病院、開業医）、地域別（北米、ヨ...

パジェット病治療の世界市場：市場規模・現状・予測

パーキンソン病治療の世界市場：市場規模・現状・予測 Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA)…
非アルコール性脂肪性肝疾患治療の世界市場：市場規模・現状・予測 Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…
ウルフパーキンソンホワイト症候群の治療の世界市場：市場規模・現状・予測 Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than no…
ウルフパーキンソンホワイト症候群の治療の世界市場：市場規模・現状・予測 Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than no…
クラッベ病治療の世界市場：市場規模・現状・予測 Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…